Frank Palantoni - Net Worth and Insider Trading
Frank Palantoni Net Worth
The estimated net worth of Frank Palantoni is at least $2 Million dollars as of 2024-04-26. Frank Palantoni is the CEO and President of Prestige Consumer Healthcare Inc and owns about 33,278 shares of Prestige Consumer Healthcare Inc (PBH) stock worth over $2 Million. Details can be seen in Frank Palantoni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank Palantoni has not made any transactions after 2006-05-19 and currently still holds the listed stock(s).
Transaction Summary of Frank Palantoni
Frank Palantoni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Palantoni owns 4 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , Central Garden & Pet Co (CENT) , and Prestige Consumer Healthcare Inc (PBH) among others .
Click here to see the complete history of Frank Palantoni’s form 4 insider trades.
Insider Ownership Summary of Frank Palantoni
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2004-11-02 | director |
| CENT | Central Garden & Pet Co | 2012-03-26 | Executive Vice President |
| PBH | Prestige Consumer Healthcare Inc | 2006-05-19 | director & President and COO |
| CENTA | Central Garden & Pet Co | 2011-02-14 | Executive Vice President |
Frank Palantoni Latest Holdings Summary
Frank Palantoni currently owns a total of 1 stock. Frank Palantoni owns 33,278 shares of Prestige Consumer Healthcare Inc (PBH) as of May 19, 2006, with a value of $2 Million.
Latest Holdings of Frank Palantoni
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PBH | Prestige Consumer Healthcare Inc | 2006-05-19 | 33,278 | 70.14 | 2,334,119 |
Holding Weightings of Frank Palantoni
Frank Palantoni Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Palantoni has made a total of 0 transactions in Prestige Consumer Healthcare Inc (PBH) over the past 5 years. The most-recent trade in Prestige Consumer Healthcare Inc is the acquisition of 2,390 shares on May 19, 2006, which cost Frank Palantoni around $24,832.
Insider Trading History of Frank Palantoni
- 1
Frank Palantoni Trading Performance
GuruFocus tracks the stock performance after each of Frank Palantoni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Palantoni is -9.66%. GuruFocus also compares Frank Palantoni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Palantoni within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Palantoni's insider trading performs compared to the benchmark.
Performance of Frank Palantoni
Average Return
19.69%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.26 | -9.66 | 11.66 | 19.69 | -2.03 | -16.48 |
| Relative Return to S&P 500(%) | -3.14 | -12.44 | 1.07 | -0.49 | -8.13 | -5.98 |
Frank Palantoni Ownership Network
Ownership Network List of Frank Palantoni
Ownership Network Relation of Frank Palantoni
Frank Palantoni Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Frank Palantoni is the director of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Frank Palantoni made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Frank Palantoni Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Palantoni. You might contact Frank Palantoni via mailing address: 90 North Broadway, Irvington Ny 10533.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
